During the past decade, Gynecologic Oncology Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 19 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gynecologic Oncology Group" #1 collaborator was "National Cancer Institute (NCI)" with 31 trials as a collaborator, "Gynecologic Oncology Group" with 25 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "Medical Research Council" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Gynecologic Oncology Group" are "Primary Peritoneal Cavity Cancer" (12 trials), "Stage III Uterine Corpus Cancer" (11 trials), "Recurrent Ovarian Epithelial Cancer" (10 trials), "Stage IV Uterine Corpus Cancer" (10 trials) and "Endometrial Adenocarcinoma" (9 trials). Many other conditions were trialed in "Gynecologic Oncology Group" in a lesser frequency.

Most popular intervention types in "Gynecologic Oncology Group" are "Drug" (42 trials), "Other" (33 trials), "Biological" (12 trials), "Procedure" (12 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "laboratory biomarker analysis" (12 trials), "Gemcitabine Hydrochloride" (6 trials), "Cisplatin" (5 trials) and "Paclitaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Gynecologic Oncology Group" are 60 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Gynecologic Oncology Group". 5 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in Gynecologic Oncology Group, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Gynecologic Oncology Group, 6 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".